| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.ssorganics.co.in | |
| Market Cap | 117.19 Cr. | |
| Enterprise Value(EV) | 185.08 Cr. | 2023-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -4.31 | Trailing Twelve Months Ending 2023-06 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-06 |
| Industry PE | 37.95 | Trailing Twelve Months Ending 2023-06 |
| Book Value / Share | -6.52 | Trailing Twelve Months Ending 2023-06 |
| Price to Book Value | -5.37 | Calculated using Price: 35.00 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 3.35 Cr. | 33,483,500 Shares |
| FaceValue | 10 | |
| About Oxygenta Pharmaceutical Ltd. | ||
| SS Organics was incorporated in 1990, is a pharmaceutical company involved in the manufacture and marketing of bulk drugs and intermediates. | ||
| 1 Day |
|
-3.85% |
| 1 Week |
|
-5.79% |
| 1 Month |
|
+7.59% |
| 3 Month |
|
-3.69% |
| 6 Month |
|
-9.14% |
| 1 Year |
|
+27.04% |
| 2 Year |
|
+2.64% |
| 5 Year |
|
+274.33% |
| 10 Year |
|
+386.11% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | ||||||||||
| Return on Capital Employed (%) | -183.16 | 3.18 | ||||||||
| Return on Assets (%) | -24.53 | -33.71 | -29.05 | -29.92 | -25.13 | -17.07 | -29.10 | 11.16 | -1.88 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
| Shh. Funds | -9 | -16 | -22 | -27 | -32 | -35 | -41 | -38 | -35 | -46 | |
| Non Curr. Liab. | 15 | 18 | 21 | 31 | 31 | 40 | 44 | 54 | 58 | 74 | |
| Curr. Liab. | 12 | 16 | 21 | 16 | 18 | 17 | 16 | 18 | 8 | 26 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 18 | 18 | 20 | 19 | 17 | 21 | 19 | 34 | 31 | 54 | |
| Non Curr. Assets | 17 | 13 | 14 | 13 | 13 | 12 | 12 | 18 | 22 | 29 | |
| Curr. Assets | 2 | 5 | 5 | 6 | 4 | 9 | 7 | 16 | 10 | 25 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 18 | 18 | 20 | 19 | 17 | 21 | 19 | 34 | 31 | 54 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
| Net Sales | 2 | 6 | 12 | 8 | 13 | 21 | 14 | 52 | 61 | 29 | |
| Other Income | 0 | 0 | 1 | 1 | 0 | 0 | 0 | ||||
| Total Income | 3 | 6 | 12 | 9 | 14 | 21 | 14 | 52 | 61 | 29 | |
| Total Expenditure | -6 | -10 | -17 | -13 | -17 | -23 | -22 | -48 | -59 | -39 | |
| PBIDT | -3 | -4 | -4 | -4 | -3 | -2 | -8 | 4 | 1 | -10 | |
| Interest | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -2 | -1 | -2 | |
| Depreciation | -1 | -3 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -2 | |
| Taxation | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Exceptional Items | 4 | 2 | 1 | -1 | |||||||
| PAT | -4 | -6 | -6 | -6 | -5 | -3 | -6 | 3 | -1 | -14 | |
| Adjusted EPS | -4 | -6 | -5 | -6 | -4 | -3 | -6 | 3 | 0 | -8 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | -1 | -3 | -4 | 1 | 1 | 1 | -8 | -3 | -2 | -2 | |
| Cash Fr. Inv. | -3 | -2 | 1 | -2 | -1 | 0 | -1 | -1 | -7 | -5 | |
| Cash Fr. Finan. | 4 | 4 | 3 | 1 | 0 | -1 | 8 | 3 | 9 | 6 | |
| Net Change | 1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Cash Eqvt | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Thu, 07 Sep 2023
Reg. 34 (1) Annual Report. Submission of copy of Annual report along with Notice of Annual General Meeting (AGM) as required under Regulation 34(1) of SEBI (LODR) Regulations 2015. |
|
Mon, 04 Sep 2023
Announcement under Regulation 30 (LODR)-Change in Directorate Board of directors appointed Mr. Sunel Vishram Chawda as Additional director in the Executive category Mrs.Sravani Reddy Gantla as an Additional Director in the Executive category and Mr. Bharath Reddy Guntuku as The Additional Director in Independent category. |
|
Mon, 04 Sep 2023
Board Meeting Outcome for Outcome Of Board Meeting Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations") read with Schedule III to the said Regulations this is to inform you that the Board of directors of the Company at their meeting held on Monday 04th September 2023 inter alia transacted the following items of business: |
| Thu, 21 Sep 2023 |
Close Crossing Last Week Low
|
Close Crossing Last Month Close from Above
|
Opening at High
|
Opening at Low
|
Close Below Last Week Low
|
Equities
M.F.
Sectors
StockEdge Social